Isosorbide mononitrate and Injection site mass - a phase IV clinical study of FDA data

Summary:

Injection site mass is reported as a side effect among people who take Isosorbide mononitrate (isosorbide mononitrate), especially for people who are female, 50-59 old, also take Vitamin D3, and have Fatigue.

The phase IV clinical study analyzes which people have Injection site mass when taking Isosorbide mononitrate. It is created by eHealthMe based on reports of 26,444 people who have side effects when taking Isosorbide mononitrate from the FDA, and is updated regularly.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.

What is Injection site mass?

Injection site mass is found to be associated with 836 drugs and 786 conditions by eHealthMe. Check the latest studies of Injection site mass.

On Jul, 07, 2026

26,444 people reported to have side effects when taking Isosorbide mononitrate.
Among them, 22 people (0.08%) have Injection site mass.

Could Isosorbide mononitrate cause Injection site mass?

Among these 22 people:

What is the gender of people who have Injection site mass when taking Isosorbide mononitrate? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Injection site mass when taking Isosorbide mononitrate? *

What are other drugs people take besides Isosorbide mononitrate? *

Aspirin: 10 people, 45.45%
Vitamin D3: 10 people, 45.45%
Magnesium: 9 people, 40.91%
Acetaminophen: 8 people, 36.36%
Epinephrine: 8 people, 36.36%
Atenolol: 8 people, 36.36%
Diphenhydramine Hydrochloride: 7 people, 31.82%
Omeprazole: 7 people, 31.82%
Trulicity: 6 people, 27.27%
Jardiance: 6 people, 27.27%

What are other side effects people have besides Injection site mass? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 36.36%
Injection Site Pain: 7 people, 31.82%
Rashes (redness): 6 people, 27.27%
Nausea (feeling of having an urge to vomit): 6 people, 27.27%
Abdominal Discomfort: 5 people, 22.73%
Injection Site Infection: 5 people, 22.73%
Chronic Kidney Disease: 5 people, 22.73%
Injection Site Scar: 5 people, 22.73%
Fever: 5 people, 22.73%
Lower Respiratory Tract Infection: 5 people, 22.73%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 22.73%
Fatigue (feeling of tiredness): 5 people, 22.73%
High Blood Cholesterol: 4 people, 18.18%
Type 2 Diabetes: 4 people, 18.18%
Immune System Disorder: 3 people, 13.64%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 13.64%
Infection: 2 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.55%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 4.55%
Depression: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and have Injection site mass?

- Check whether Injection site mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isosorbide mononitrate:

Isosorbide mononitrate (26,858 reports)

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site mass:

Injection site mass (836 drugs)

Browse all the conditions that are associated with Injection site mass:

Injection site mass (786 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Isosorbide mononitrate) and Isosorbide mononitrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.